| Announce Date | 02/02/2026 |
| EPS Normalized Actual | $0.16 (Beat by $0.02) |
| EPS GAAP Actual | $0.16 (Beat by $0.02) |
| Revenue Actual | $2148.33B |
| Revenue Surprise | Beat by $2148330M |
| Announce Date | 03/29/2026 (Pre-Market) |
| EPS Normalized Estimate | $20.47061 |
| EPS GAAP Estimate | $20.47061 |
| Revenue Estimate | $890.209016055B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Mar 2030 | 110.98156 | 0.09 | 96.95152 | 120.19516 | 1 |
| Mar 2029 | 75.45898 | 0.13 | 75.45898 | 75.45898 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 32.09 | 32.09 | 2148.33B | 56.04% | 2148330M |
| FQ2 2025 (Jun 2025) | 23.1 | 23.1 | 2011.33B | -12.81% | 2011330M |
| FQ1 2025 (Mar 2025) | 0 | 0 | 1936.97B | -15.58% | 1936970M |
| FQ4 2024 (Dec 2024) | 114.11 | 114.11 | 964.935B | 20.64% | 964935M |
| FQ3 2024 (Sep 2024) | 0 | 0 | 944.501B | 21.54% | 944501M |
| FQ2 2024 (Jun 2024) | 114.14 | 114.14 | 2268.92B | 69.38% | 2268920M |
| FQ1 2024 (Mar 2024) | 14.47 | 14.47 | 2238.68B | 67.47% | 2238680M |
| FQ4 2023 (Dec 2023) | 0 | 0 | 765.808B | 12.82% | 765808M |
FQ4 Announce Date
03/29/2026 (Pre-Market)
Consensus EPS Estimates
20.47061
Consensus Revenue Estimates
890.209016055B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2028 (Mar 2028) | 31.04054 | -- | 29.28537 | 34.04513 | 1 |
| FQ4 2027 (Dec 2027) | 36.98256 | -- | 34.8914 | 40.56231 | 1 |
| FQ3 2027 (Sep 2027) | 30.63853 | -- | 28.90609 | 33.60421 | 1 |
| FQ2 2027 (Jun 2027) | 25.5101 | -- | 24.06765 | 27.97937 | 1 |
| FQ1 2027 (Mar 2027) | 30.07339 | -- | 28.37291 | 32.98436 | 1 |
| FQ4 2026 (Dec 2026) | 29.71389 | -- | 28.03374 | 32.59006 | 1 |
| FQ3 2026 (Sep 2026) | 22.54175 | -42.36 | 22.54175 | 22.54175 | 1 |
| FQ2 2026 (Jun 2026) | 24.82403 | 6.95 | 24.60508 | 25.04298 | 1 |
| FQ1 2026 (Mar 2026) | 20.47061 | -- | 20.29006 | 20.65116 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2028 (Mar 2028) | 1039.14B | -- | 993.94B | 1116.51B | 1 |
| FQ4 2027 (Dec 2027) | 1094.6B | -- | 1046.98B | 1176.1B | 2 |
| FQ3 2027 (Sep 2027) | 1013.97B | -- | 969.87B | 1089.47B | 2 |
| FQ2 2027 (Jun 2027) | 929.28B | -- | 888.86B | 998.47B | 2 |
| FQ1 2027 (Mar 2027) | 965.11B | -- | 923.14B | 1036.97B | 2 |
| FQ4 2026 (Dec 2026) | 1020.31B | -- | 975.93B | 1096.28B | 1 |
| FQ3 2026 (Sep 2026) | 927.97B | -131.51 | 927.97B | 927.97B | 1 |
| FQ2 2026 (Jun 2026) | 920.71B | -118.45 | 914.46B | 926.95B | 1 |
| FQ1 2026 (Mar 2026) | 890.21B | -117.59 | 884.17B | 896.25B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
0
EPS # of in-lines
3
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 32.09 | 32.09 | 100% | |
| FQ2 2025 (Jun 2025) | 23.1 | 23.1 | 100% | |
| FQ1 2025 (Mar 2025) | 0 | 0 | NAN% | |
| FQ4 2024 (Dec 2024) | 114.11 | 114.11 | 100% | |
| FQ3 2024 (Sep 2024) | 0 | 0 | NAN% | |
| FQ2 2024 (Jun 2024) | 114.14 | 114.14 | 100% | |
| FQ1 2024 (Mar 2024) | 14.47 | 14.47 | 100% | |
| FQ4 2023 (Dec 2023) | 0 | 0 | NAN% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $2148.33B | $2148330M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $2011.33B | $2011330M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $1936.97B | $1936970M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $964.94B | $964935M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $944.5B | $944501M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $2268.92B | $2268920M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $2238.68B | $2238680M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $765.81B | $765808M | 100% |